Care pathways for the selection of a biologic in severe asthma.

EUROPEAN RESPIRATORY JOURNAL（2017）

引用 87|浏览23

暂无评分

摘要

Physicians need care pathways to select a biologic in type 2 severe asthma (omalizumab, mepolizumab, reslizumab) http://ow.ly/pygw30gB7Bv

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要